A carregar...
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
Chimeric antigen receptor (CAR)-modified T cells and bispecific T cell–engaging antibodies have demonstrated dramatic clinical responses in recent clinical trials. The hallmark of these novel highly active immunotherapies is nonphysiologic T cell activation, which has correlated not only with greatl...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4119809/ https://ncbi.nlm.nih.gov/pubmed/24667956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000035 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|